Fig. 5From: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells GSK484 inhibits tumor growth and reverses radioresistance in vivo. C666-1 cells treated with 10 µm GSK484 or 0 µm GSK484 were injected into mice, n = 4, tumor growth curves (a), weights (b) and images (c). Unpaired Student’s test. *p < 0.05, **p < 0.01Back to article page